[HTML][HTML] Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential …
H Dhandapani, H Jayakumar, A Seetharaman… - Cancer Cell …, 2021 - Springer
Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate …
H Dhandapani, H Jayakumar… - Cancer Cell …, 2021 - search.proquest.com
Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
[PDF][PDF] Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: A potential …
H Dhandapani - scholar.archive.org
Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune
system, and in particular tumour-speci c cytotoxic T lymphocytes (CTLs) to eradicate the …
system, and in particular tumour-speci c cytotoxic T lymphocytes (CTLs) to eradicate the …
Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: A potential candidate …
H Dhandapani, H Jayakumar, A Seetharaman… - 2020 - researchsquare.com
Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune
system, and in particular tumour-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
system, and in particular tumour-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate …
H Dhandapani, H Jayakumar… - Cancer cell …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
[HTML][HTML] Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential …
H Dhandapani, H Jayakumar… - Cancer Cell …, 2021 - ncbi.nlm.nih.gov
Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate …
H Dhandapani, H Jayakumar… - Cancer Cell …, 2021 - europepmc.org
Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate …
H Dhandapani, H Jayakumar… - Cancer Cell …, 2021 - search.ebscohost.com
Abstract Background: Dendritic cell (DC)-based immunotherapy is capable of activating the
immune system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate …
immune system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate …
[HTML][HTML] Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential …
H Dhandapani, H Jayakumar… - Cancer Cell …, 2021 - cancerci.biomedcentral.com
Dendritic cell (DC)-based immunotherapy is capable of activating the immune system and in
particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the tumor. However …
particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the tumor. However …
Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate …
H Dhandapani, H Jayakumar, A Seetharaman… - Cancer Cell …, 2021 - go.gale.com
Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …
system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the …